CompletedNCT00864123
D-cycloserine added to CBT for children with OCD
About this title
Read the official source — NCT00864123Medication studyAges 8–17United States
Understand this study
Who was this study for?
Listed age limits: 8 years to 17 years.
- Listed locations
- St. PetersburgSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJanuary 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- University of South Florida
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 8 Years to 17 Years
- Official registry ID
- NCT00864123
- Official title
Show the full official title
D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
St. Petersburg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of South Florida, a university.
Did this study involve medication?
Yes. The study involved medication, including D-cycloserine and Placebo pill.
Who was this study for?
Listed age limits: 8 years to 17 years.
